Healthcare Equipment and Supplies
Company Overview of ConforMIS, Inc.
ConforMIS, Inc., a medical technology company, develops, manufactures, and sells customized joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iUni G2, a unicompartmental product for treatment of the medial or lateral compartment of the knee; and iDuo G2, a bicompartmental partial implant for patients with osteoarthritis of the patellofemoral compartment of the knee and either the medial or lateral compartment of the knee, as well as provides iJigs, customized single-use patient-specific instruments. It is also developing iTotal Hip, a customized...
28 Crosby Drive
Bedford, MA 01730
Founded in 2004
Key Executives for ConforMIS, Inc.
Founder, Chief Executive Officer, President, Director and Chairman of Asia Strategy Committee
Total Annual Compensation: $365.0K
Chief Financial Officer
Total Annual Compensation: $231.9K
Chief Technology Officer
Total Annual Compensation: $230.1K
Compensation as of Fiscal Year 2014.
ConforMIS, Inc. Key Developments
ConforMIS, Inc.(NasdaqGS:CFMS) added to NASDAQ Composite Index
Jul 20 15
ConforMIS, Inc. has been added to Nasdaq Composite Index.
ConforMIS, Inc. Announces Restated Certificate of Incorporation
Jul 8 15
On July 7, 2015, ConforMIS, Inc. filed a restated certificate of incorporation with the Secretary of State of the State of Delaware in connection with the closing of the initial public offering of shares of the Company's common stock. The company's board of directors and stockholders previously approved the restated certificate to be filed in connection with, and to be effective upon, the closing of the IPO. The restated certificate amends and restates in its entirety the Company's certificate of incorporation to, among other things: authorize 200,000,000 shares of common stock; eliminate all references to the previously existing series of preferred stock; authorize 5,000,000 shares of undesignated preferred stock that may be issued from time to time by the company's board of directors in one or more series; establish a classified board of directors, divided into three classes with staggered three-year terms, with one class of directors to be elected at each annual meeting of the company's stockholders; provide that the authorized number of directors may be changed only by the resolution of the company's board of directors, subject to the rights of any holders of any then outstanding series of preferred stock; provide that directors may be removed from office only for cause and only upon the affirmative vote of the holders of at least 75% of the votes that all of the company's stockholders would be entitled to cast in an election of directors; provide that any vacancy on the company's board of directors, including a vacancy resulting from an enlargement of the board of directors, may be filled only by vote of a majority of the directors then in office, subject to the rights of any holders of any then outstanding series of preferred stock; and eliminate the ability of the Company's stockholders to take action by written consent in lieu of a meeting and call special meetings of stockholders.
ConforMIS Might Seek Acquisitions
May 22 15
ConforMIS, Inc. has filed an IPO in the amount of $172.50 million. Although ConforMIS has no current agreements, commitments or understandings for any specific acquisitions or in-licenses at this time, it may use a portion of the net proceeds for these purposes.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|